Description: Grifols, global healthcare leader in producing plasma derived medicines and other innovative biopharmaceutical solutions, is dedicated to improving the health and well-being of patients.
Q1 2023 Earnings Results on May 9, 2023. Please click here to access the webinar scheduled at 2:30pm CET.
Since 1909, Grifols has worked to improve the health and well-being of people around the world.
Every action we take is motivated by our mission to improve people's lives.